LJAC
IDXX icon

L.J. Altfest & Co’s Idexx Laboratories IDXX Stock Holding History

L.J. Altfest & Co’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-967
Closed -$519K – 353
2025
Q2 		$519K Buy
+967
New +$462K 0.06% 212
2022
Q3 		– Sell
-739
Closed -$259K – 269
2022
Q2 		$259K Buy
+739
New +$301K 0.05% 220

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

L.J. Altfest & Co's IDXX Position: Q3 2025 in Review

L.J. Altfest & Co sold out of Idexx Laboratories (IDXX) in Q3 2025, closing a stake of 967 shares — an estimated $519K sold.

L.J. Altfest & Co first reported a position in IDXX in Q2 2022 and held it in 2 quarters. The position peaked at $519K in Q2 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • L.J. Altfest & Co reported no remaining Idexx Laboratories position as of Q3 2025 after selling out during the quarter.
  • L.J. Altfest & Co sold 967 Idexx Laboratories shares in Q3 2025, an estimated $519K.
  • L.J. Altfest & Co first reported a position in Idexx Laboratories in Q2 2022 and held it in 2 quarters.
  • L.J. Altfest & Co's Idexx Laboratories position peaked at $519K in Q2 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on L.J. Altfest & Co's 13F filing for Q3 2025, filed 21 Oct 2025.